On April 29, the U.S. the Food and Drug Administration (FDA) approved Nuplazid (pimavanserin) tablets, the first drug approved to treat hallucinations and delusions associated with psychosis experienced…
Reader Survey
Please share your feedback! We’re interested to learn more about your experience with American Nurse Journal.